Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Sued By AbbVie Inc For Infringement Of Thyroid Injection Patent-Business Line


Tuesday, 18 Jun 2013 08:00pm EDT 

Business Line reported that US-based drug maker AbbVie Inc, the spun-off entity of Abbott, has dragged Dr.Reddy's Laboratories Ltd to court for allegedly infringing the former’s patented drug Zemplar on six counts concerning three patents. The US drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL’s generic paricalcitol injectable products prior to the expiration of the said patents. 

Company Quote

3409.9
28.95 +0.86%
5:59am EDT